Efficacy and Safety of Non-Cross-Linked Hyaluronic Acid Compound in the Treatment of Keratosis Pilaris: A Split-Body Randomized Clinical Trial
August 2024
in “
Journal of Cosmetic Dermatology
”
Studysummary This study reports that injecting a non-cross-linked hyaluronic acid compound into keratosis pilaris-affected skin led to significant improvements in roughness, redness, and overall skin condition, while maintaining a favorable safety profile, making it a promising alternative treatment option.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →